Exact Sciences Corporation
EXASNASDAQHealthcare
$104.91
+$0.00(+0.00%)
Market Cap$20.0B
P/E Ratio—
52W High$104.98
52W Low$38.81
Exact Sciences Corporation (EXAS) · Cash Flow
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · EXAS · as of 2026-06-10
Financial statements
Operating CF · CapEx · Free Cash Flow
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | ($0.21B) | ($1.03B) | ($0.20B) | ($0.62B) | ($0.60B) |
| Depreciation & Amort. | $0.22B | $0.21B | $0.21B | $0.20B | $0.18B |
| Stock-Based Comp. | $0.22B | $0.21B | $0.23B | $0.21B | $0.25B |
| Change in Working Capital | $0.12B | ($0.06B) | ($0.00B) | ($0.03B) | $0.11B |
| Net Cash from Operations | $0.49B | $0.21B | $0.16B | ($0.22B) | ($0.10B) |
| Investing Activities | |||||
| Capital Expenditure | ($0.13B) | ($0.14B) | ($0.12B) | ($0.21B) | ($0.14B) |
| Purchases of Investments | ($0.20B) | ($0.47B) | ($0.16B) | ($0.17B) | ($1.16B) |
| Sales of Investments | $0.57B | $0.21B | $0.38B | $0.45B | $0.79B |
| Net Cash from Investing | $0.20B | ($0.44B) | $0.05B | $0.07B | ($1.08B) |
| Financing Activities | |||||
| Common Stock Repurchased | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Dividends Paid | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Debt Issued / Repaid | ($0.25B) | $0.22B | $0.14B | $0.05B | ($0.02B) |
| Net Cash from Financing | ($0.34B) | $0.23B | $0.16B | $0.08B | $0.01B |
| Free Cash Flow | |||||
| Free Cash Flow | $0.36B | $0.07B | $0.03B | ($0.44B) | ($0.24B) |
| FCF Margin %(computed) | 10.99% | 2.70% | 1.28% | -21.02% | -13.47% |
Data source: Financial Modeling Prep · Last updated: 2026-06-10 · USD · B
Explore more Exact Sciences Corporation data
About Exact Sciences Corporation (EXAS) Cash Flow Statement
Exact Sciences Corporation generated operating cash flow of $0.49B and free cash flow of $0.36B for 2025 — a FCF margin of 10.99%. Capital expenditure was ($0.13B).
Frequently asked questions
EXAS · 4 questionsExact Sciences Corporation generated free cash flow of $0.36B for 2025, up 378.6% year-over-year.
EXAS free cash flowFCF margincash flow yield
· Source: FMP /stable/cash-flow-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-10